Conference icon

Conference

A meta-analysis of two randomized, double-blind, placebo-controlled, phase III studies in patients (pts) with metastatic colorectal cancer (mCRC) receiving FOLFOX4 and PTK/ZK to determine clinical benefit on progression-free survival (PFS) in high LDH pts.

Publication status:
Published

Actions


Authors


Trarbach, T More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, Clinical Lab Sciences, Biomedical Research Centre
Pendergrass, K More by this author
Expand authors...
Volume:
24
Issue:
18
Pages:
153S-153S
Publication date:
2006-06-20
ISSN:
0732-183X
URN:
uuid:ae2d9fae-f518-4fe2-9291-538477bf4628
Source identifiers:
346509
Local pid:
pubs:346509

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP